Coherus Biosciences | 现金及等价物



金融业
股票价格
USD
资产
USD 516.52M
现金及等价物
USD 103.35M
销售成本
USD 2.65M
流动资产
USD 460.96M
流动负债
USD 372.3M
债务
USD 294.93M
股息收益率
0
EBIT
USD -45.44M
EBITDA
USD -44.34M
员工
306
EPS每股收益
USD -0.35
股本和储备
USD 87.77M
销售毛利
USD 4.95M
债务利息支出
USD 2.15M
贷款资金
USD 294.85M
市值
USD 188.2M
净收入
USD -56.57M
营业费用
USD 53.03M
营业利润
USD -45.44M
普通股股本
USD 12K
税前利润
USD -47.4M
销售收入
USD 7.6M
销售和管理费用
USD 26.03M
股票
USD 2.05M
贸易债权人
USD 24.89M
应收帐款人
USD 62.44M


现金及等价物 更改 日
AbbVie USD 5.23B 400M 2025-12
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Akebia Therapeutics USD 184.84M 18.4M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 103.35M 113.54M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Fujifilm JPY 160.88B 906M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Myriad Genetics USD 145.4M 71M 2025-09
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xencor USD 54.07M 25.78M 2025-12
Zoetis USD 2.08B 649M 2025-09


Coherus Biosciences 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.